Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells
As cyclin-dependent kinases (CDKs) regulate cell cycle progression and RNA transcription, CDKs are attractive targets for creating cancer cell treatments. In this study we investigated the effects of the small molecular agent NU6140 (inhibits CDK2 and cyclin A interaction) on human embryonic stem (h...
Saved in:
| Main Authors: | Ade Kallas, Martin Pook, Annika Trei, Toivo Maimets |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | International Journal of Cell Biology |
| Online Access: | http://dx.doi.org/10.1155/2014/280638 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog)
by: SoHyun Lee, et al.
Published: (2017-04-01) -
Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2.
by: Carlos F Pereira, et al.
Published: (2008-09-01) -
Expression of the stem cell markers NANOG and SOX2 in the cervical squamous carcinogenesis
by: Koren Miha, et al.
Published: (2025-04-01) -
Structural characterization of stem cell factors Oct4, Sox2, Nanog and Esrrb disordered domains, and a method to detect phospho-dependent binding partners
by: Bouguechtouli, Chafiaa, et al.
Published: (2024-04-01) -
XPC Promotes Pluripotency of Human Dental Pulp Cells through Regulation of Oct-4/Sox2/c-Myc
by: Lu Liu, et al.
Published: (2016-01-01)